1.
Product Overview
2.
Research Methodology
3.
Impact of COVID-19 on Acyclovir Market
4.
Executive Summary
5.
Manufacturing Acyclovir
5.1.
Raw Material
5.2.
Machinery
5.3.
Manufacturing Methods
5.4.
Contact Details of Machinery & Raw Material Suppliers
6.
Pharmacodynamic Overview of Acyclovir
6.1.
Mechanism of Action
6.2.
Absorption
6.3.
Volume of Distribution
6.4.
Protein Binding
6.5.
Metabolism
6.6.
Route of Elimination
6.7.
Half-Life
6.8.
Clearance
6.9.
Toxicity
7.
India Acyclovir Market Outlook
7.1.
Market Size & Forecast
7.1.1. By Value &
Volume
7.2.
Market Share & Forecast
7.2.1. By Source (In-house
v/s Contract Manufacturing Organizations)
7.2.2. By Form (Tablet,
Capsule, Ointment/Cream, Injection, Powder for Solution, Others)
7.2.3. By Route of
Administration (Oral, Injectable, Topical, Others)
7.2.4. By Type of Virus
(Herpes Simplex Virus Type I (HSV-1), Herpes Simplex Virus Type II (HSV-2),
Varicella Zoster Virus (VZV), Epstein-Barr Virus (EBV), Cytomegalovirus (CMV))
7.2.5. By Mechanism of
Action (Nucleotide Polymerase Inhibitors, Reverse Transcriptase Inhibitors,
Protease Inhibitors, Others)
7.2.6. By Distribution
Channel (Online v/s Offline)
7.2.7. By Application (Cold
Soares, Chickenpox, Genital Herpes, Shingles, Hepatitis, HIV, Influenza,
Others)
7.2.8. By End User
(Children up to 12 years v/s Adults)
7.2.9. By Region (North,
East, South, West)
7.2.10. By Company
7.3.
Product Market Map
8.
Market Dynamics
8.1.
Drivers/Opportunities
8.2.
Challenges/Restraints
9.
Market Trends & Developments
10.
Policy & Regulatory Landscape
10.1.
Custom Duty & Taxes
10.2.
Government Subsidy & Benefits
10.3.
Relevant Policies & Regulations (GMP, USFDA, WHO Certifications)
11.
Import & Export Analysis
12.
Pricing Analysis
13.
India Economic Profile
14.
Competitive Landscape
14.1.
Company Profiles
14.1.1. Cipla Limited
14.1.1.1. Company Brief
14.1.1.2. Production Plants
& Capacity (If Available)
14.1.1.3. Financials (If
Available)
14.1.1.4. Captive Consumption
Vs Merchant Sale
14.1.1.5. Current & Future
Plans
14.1.2. Agio Pharmaceuticals
Limited
14.1.3. Zee Laboratories
Limited
14.1.4. Novus Life Sciences
Pvt. Ltd.
14.1.5. Terrace
Pharmaceuticals Pvt. Ltd.
14.1.6. Grefith Life
Sciences Private Limited
14.1.7. Samarth Life Sciences
Pvt. Ltd.
14.1.8. Novartis India
Limited (Sandoz Private Limited)
14.1.9. Cadila Healthcare
Limited
14.1.10.
Eli Lilly and Company India Pvt Ltd
15.
Strategic Recommendations
16.
About Us & Disclaimer